France-based cultivated protein company Parima has received authorization from the Singapore Food Agency (SFA) for its cultivated duck, becoming the first cultivated meat company to hold regulatory approval for two animal species.
The clearance follows the company’s cultivated chicken approval in Singapore in October 2025, which was originally submitted by Vital Meat prior to its merger with Gourmey to form Parima. Both products are produced from avian cells grown in controlled bioreactors and differentiated into muscle and fat tissue.
“Repeatable regulatory success is becoming a clear marker of platform strength”
Parima intends to launch its cultivated duck through high-end gastronomy channels in Singapore. The chicken product is positioned for broader foodservice and future retail applications.
“The approval of our cultivated duck product marks a new chapter not only for Parima, but for cultivated food more broadly. In a sector moving from promise to proof, repeatable regulatory success is becoming a clear marker of platform strength,” said CEO Nicolas Morin-Forest.
Platform approach across species
Parima was formed in October 2025 when Paris-based Gourmey acquired fellow French cultivated meat company Vital Meat. The merger combined Gourmey’s full-stack production facilities with Vital Meat’s 2,000-litre bioreactor capacity and advanced avian cell lines, and brought together 15 patent families and more than 70 applications.
Gourmey had previously achieved independently verified production costs below €7/kg (US$8.19/kg), enabled by high-density cell lines, full suspension culture, and growth factor–free feed. The company projects a pathway to sub-€10/kg production across species at scale.
Parima’s platform produces cultivated meat using efficient cell lines in industrial bioreactors, without genetic engineering or scaffolding.
Global regulatory pipeline
The duck approval is the second in what Parima describes as an extensive international regulatory pipeline. The company holds eight active filings across major international markets, including the EU, where it was the first company to seek novel food approval for a cultivated food, and the UK, where its dossiers are among the most advanced currently under review.
Parima’s two consecutive approvals reflect a broader shift in the cultivated meat industry: the ability to validate a production platform not just for a single product, but reproducibly across species and regulatory frameworks. Nicolas Morin-Forest and Etienne Duthoit are scheduled to attend Food & Hospitality Asia 2026 in Singapore next week.
